Intravenous (IV) Therapy and Vein Access Market Size, Share, Overview and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Intravenous (IV) Therapy and Vein Access Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the global intravenous (IV) therapy and vein access market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the intravenous (IV) therapy and vein access market?

The global intravenous (IV) therapy and vein access market size reached US$ 23.85 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.83 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028.

What are the growth prospects and trends in the intravenous (IV) therapy and vein access industry?

The escalating prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune illnesses that require long-term medication and monitoring, is primarily driving the intravenous (IV) therapy and vein access market. Besides this, the high incidences of road accidents and trauma cases, the increasing consumer awareness toward the benefits of this treatment, the rise in critical care therapies, and the preference for minimally invasive procedures are further augmenting the market growth. Moreover, technological advancements in the healthcare industry, aimed at reducing procedure time and effort, lowering infection risks, and improving accuracy, are also catalyzing the global market. Apart from this, the rising research and development activities to innovate new therapies, drugs, and devices are acting as significant growth-inducing factors. Furthermore, the inflating healthcare expenditure, the expanding number of hospitals, the extensive utilization of home healthcare, and the elevating geriatric population are anticipated to propel the intravenous (IV) therapy and vein access market over the forecasted period.

Request for a free sample copy of this report: https://www.imarcgroup.com/intravenous-therapy-vein-access-market/requestsample

What is Intravenous (IV) Therapy and Vein Access?

Intravenous therapy refers to a medical procedure in which fluids, medications, and nutrients are directly delivered into the bloodstream through a vein. It is a widely utilized technique in healthcare facilities, such as hospitals and clinics, for the treatment of various conditions and diseases. Vein access, which involves entering a vein to administer IV therapy, can be challenging in certain patients due to factors, including small or damaged veins, dehydration, and obesity. Healthcare professionals typically use a needle to puncture the skin and access the vein. IV therapy encompasses several types, such as saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. Additionally, this treatment is utilized for preventive measures, including receiving vaccinations and vitamins.

What is included in market segmentation?

The report has segmented the market into the following categories:

Market Breakup by Type:

• Implantable Ports
• Intravenous Catheters
• Hypodermic Needles
• Infusion Pumps
• Others

Market Breakup by Application:

• Nutrition And Buffer Solution
• Volume Expander
• Medication Administration
• Blood Based Products

Market Breakup by End User:

• Hospitals
• Ambulatory Surgical Center
• Clinics

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• AngioDynamics Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Cardinal Health Inc.
• Fresenius SE & Co. KGaA
• ICU Medical Inc.
• Medtronic plc
• Tekni-Plex Inc.
• Teleflex Incorporated
• Terumo Corporation
• Vygon SAS

Browse the full report with TOC & List of Figures: https://www.imarcgroup.com/intravenous-therapy-vein-access-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Article source: https://article-realm.com/article/Business/48319-Intravenous-IV-Therapy-and-Vein-Access-Market-Size-Share-Overview-and-Forecast-2023-2028.html